ALMS · Alumis Inc.
$22.86
-1.13 (-4.71%)
At close · Aug 20
Market Cap
$2.96B
Shares
129.44M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$22.86
Open$23.76
Day$22.03–23.93
52W close$3.95–30.30
Avg vol 30d985K
Short int5.8M · 4.5% float · 6.1d
Short vol53%
Last earningsMay 14, 2026
DataJun 2024–Aug 2026
Filing10-Q · Aug 13
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 13, 2026
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Bullish
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 14.9 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+7%
above
Price vs 50-day avg
−13%
below
RSI (14)
36
neutral
MACD trend
Negative
52-week position
72%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−19%
trailing
6-month return
−23%
trailing
YTD return
+134%
this year
Relative strength
−34%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $26 › 200d $21 — 50d above 200d
Institutional flow
Accumulating
+1% holders QoQ · +29 funds added
Insider flow
Distributing
Net -$534.3K over 90 days · 100% sells
Short interest
Falling
4.45% of float · ▼ -14.8% MoM · 6.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
201 holders — near 2-yr high, broad support
Squeeze score
58
elevated · 0–100
Fundamentals
EPS growth
+72%
Y/Y
Free cash flow
$-370.2M
Balance sheet
$89.7M
net cash
Quant / Vol
risk profile
Volatility
122%
annualized · 1-yr
Max drawdown
−37%
past year
ATR
7.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+7%
Bullish
Price vs 50-day avg
−13%
Bearish
RSI (14)
36
Neutral
MACD trend
Negative
Bearish
52-week position
72%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $26 › 200d $21 — 50d above 200d
Institutional flow
Accumulating
+1% holders QoQ · +29 funds added
Insider flow
Distributing
Net -$534.3K over 90 days · 100% sells
Short interest
Falling
4.45% of float · ▼ -14.8% MoM · 6.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
201 holders — near 2-yr high, broad support
Price context
position in its 52-week range
Range low $4
Now $23 · 72%
Range high $30
vs 200-day avg +7%
vs 50-day avg -13%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ALMS
this stock
Alumis Inc.
|
$2.96B | +134.2% | — | — | 4.5% |
|
ONC
BeOne Medicines Ltd.
|
$557.05B | +21.5% | +22179.2% | 856.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$136.93B | +19.2% | +46.2% | 31.5 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$86.39B | +7.1% | +20.8% | 20.8 | 3.3% |
|
MRNA
Moderna, Inc.
|
$69.62B | +352.1% | +4.3% | — | 12.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ALMS | -6.4% | -19.2% | -23.0% | -19.1% | +134.2% |
| SPY | -2.0% | +3.3% | +11.2% | +2.1% | +11.8% |
| vs SPY | -4.4% | -22.5% | -34.2% | -21.2% | +122.4% |
Key facts
CIK
1847367
CUSIP
022307102
13F (30d)
190 filings
186 filers
Visit website
Investor relations